<div id="readability-page-1"><div><ul> <li>In recent weeks, America's warfighters announced a framework agreement with the Department of War for an initial 3,000 Leidos Low-Cost Containerized Munitions, alongside a US$2.70 billion U.S. Army contract to advance hypersonic weapons programs toward production.</li> <li>These awards, paired with Leidos’ company-funded LCCM development and planned facility expansions in Alabama and Tennessee, underline the company’s push to scale complex defense production under its NorthStar 2030 plan.</li> <li>We’ll examine how the US$2.70 billion hypersonics contract reshapes Leidos’ investment narrative, especially its dependence on government defense funding.</li> </ul><p>Invest in the nuclear renaissance through our list of 88 elite nuclear energy infrastructure plays powering the global AI revolution.</p><h2>Leidos Holdings Investment Narrative Recap</h2><p>To own Leidos, you need to believe its deep integration into U.S. defense and national security programs will continue to convert into large, technically complex contracts, even as political priorities and budgets shift. The new US$2.70 billion hypersonics award and the initial 3,000 LCCM order both reinforce the immediate revenue pipeline, but they also intensify the company’s exposure to U.S. defense funding as the key near term catalyst and the central risk.</p> <p>Among recent announcements, the raised 2026 revenue guidance to US$18.0 billion to US$18.4 billion is most relevant here, because it reflects management’s view of demand across hypersonics, precision munitions, and AI enabled defense programs. For investors, that updated outlook ties directly into the contract momentum highlighted by the hypersonics consolidation and LCCM framework, while also framing how much depends on continued follow through from U.S. government customers.</p> <p>Yet, beneath these contract wins, Leidos’ growing reliance on U.S. defense and security budgets is something investors should be aware of, especially if...</p> <p>Read the full narrative on Leidos Holdings (it's free!)</p><p>Leidos Holdings' narrative projects $20.2 billion revenue and $1.6 billion earnings by 2029. This requires 5.5% yearly revenue growth and an earnings increase of about $0.2 billion from $1.4 billion today.</p><p>Uncover how Leidos Holdings' forecasts yield a $199.21 fair value, a 60% upside to its current price.</p><h2>Exploring Other Perspectives</h2><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/c820e437-2011-41eb-9d48-ccac1ac52038/chart/quote-price?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/c820e437-2011-41eb-9d48-ccac1ac52038/chart/quote-price"/><figcaption>LDOS 1-Year Stock Price Chart</figcaption></figure> <p>Four members of the Simply Wall St Community currently place Leidos’ fair value between US$185 and about US$270 per share, showing how far opinions can stretch. You can set those views against the company’s increased dependence on long term U.S. defense funding and consider what that might mean for performance if political or budget conditions change.</p><p>Explore 4 other fair value estimates on Leidos Holdings - why the stock might be worth just $185.00!</p><h2>The Verdict Is Yours</h2><p>Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.</p><ul><li>A great starting point for your Leidos Holdings research is our analysis highlighting 5 key rewards and 1 important warning sign that could impact your investment decision.</li><li>Our free Leidos Holdings research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Leidos Holdings' overall financial health at a glance.</li></ul><h2>Contemplating Other Strategies?</h2><p>Our top stock finds are flying under the radar-for now. Get in early:</p><ul><li>We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.</li><li>Uncover the next big thing with 29 elite penny stocks that balance risk and reward.</li><li>Find 52 companies with promising cash flow potential yet trading below their fair value.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data     and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your     financial situation. We aim to bring you long-term focused analysis driven by fundamental data.     Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.     Simply Wall St has no position in any stocks mentioned.</em></p><div><h3><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><div><p>• Dividend Powerhouses (3%+ Yield)<br/>• Undervalued Small Caps with Insider Buying<br/>• High growth Tech and AI Companies</p><p>Or build your own from over 50 metrics.</p></div><p>Explore Now for Free</p></div></div></div>

LDOS

<p>Leidos Holdings has secured a $2.70 billion U.S. Army contract for hypersonic weapons and an initial order for 3,000 Low-Cost Containerized Munitions. These developments are part of Leidos' NorthStar 2030 plan and are expected to enhance its revenue pipeline, with projected revenues of $18.0-$18.4 billion by 2026. However, the company's increasing reliance on U.S. defense funding poses risks for investors, especially amid shifting political priorities.</p>

How New Hypersonics Contract and LCCM Orders Will Impact Leidos Holdings (LDOS) Investors